Keeping Current CME

Do you know how many different types of anti-HER2 therapies are in clinical trials for gastroesophageal adenocarcinoma (GEA)?
Credit available for this activity expires: 02/27/2027
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-ground-gastroesophageal-adenocarcinoma-first-line-2026a10005tj?ecd=bdc_podcast_libsyn_mscpedu

Transforming CLL care: measurable residual disease (MRD) guided stopping, smart triplet selection, and next‑gen Bruton tyrosine kinase (BTKs)—practical insights.
 
Credit available for this activity expires: 02/19/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-lymphocytic-leukemia-cll-review-combination-2026a10004ku?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on the management of extensive-stage small cell lung cancer (ES-SCLC)?
Credit available for this activity expires: 2/20/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/quick-talk-es-sclc-what-community-clinicians-need-know-now-2026a100055m?ecd=bdc_podcast_libsyn_mscpedu

Clear communication builds trust in biosimilars. 
Credit available for this activity expires: 2/19/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003245?ecd=bdc_podcast_libsyn_mscpedu

Early evidence for CAR T-cell therapy in lupus is compelling. Are you up-to-date?
Credit available for this activity expires: 2/9/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/car-t-cells-sle-new-frontier-autoimmunity-2026a10003ow?ecd=bdc_podcast_libsyn_mscpedu